Clinical Trials Logo
  1. Home
  2. Cervix Neoplasms
  3. NCT00188539

Cervix:Hypoxia, Interstitial Fluid Pressure and GSH Levels

Cervix Neoplasms Clinical Trial

Official title:
Predictive Assays in Cervix Cancer: Assessment of Hypoxia, Interstitial Fluid Pressure, and GSH Levels

Clinical Trial Summary

The aim of this study is to measure the oxygen content and interstitial fluid pressure in cervix cancer patients. Tumour oxygen content and internal pressure of tumours may be an important factor that influences the effectiveness of radiotherapy and other treatments.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00188539
Study type Interventional
Source University Health Network, Toronto
Contact
Status Active, not recruiting
Phase Phase 2
Start date December 1995
Completion date December 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT00069160 - Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer Phase 2
Completed NCT00084123 - Healing Touch and Relaxation Therapies in Cervical Cancer Patients Phase 2
Active, not recruiting NCT00039884 - Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia? Phase 2
Completed NCT00127465 - Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants Phase 1/Phase 2
Completed NCT02184975 - Cold Knife Conization With and Without Lateral Hemostatic Sutures Phase 2
Completed NCT00112307 - Magnetic Resonance Imaging Guided Gynecologic Brachytherapy N/A
Recruiting NCT04295109 - Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function N/A
Completed NCT00188578 - Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2) Phase 1/Phase 2
Active, not recruiting NCT00178802 - Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers Phase 2
Active, not recruiting NCT00119509 - The IMAP Study Improving Management of Mildly Abnormal Pap Smears Phase 3
Completed NCT00288821 - Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology N/A
Completed NCT00152828 - Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the Cervix Phase 1/Phase 2
Completed NCT00188695 - Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide Phase 1/Phase 2